 XII. To determine response to sirolimus, docetaxel and carboplatin in tumors with mutation of DNA repair pathway genes breast cancer gene 2 BRCA2, ataxia telangiectasia mutated ATM and other Fanconi anemia complementation groups FANC pathway members. Phase II 